Author:
Ryan Nicola J.,Lo Jin Han
Publisher
Springer Science and Business Media LLC
Reference18 articles.
1. van den Boogaard J, Kibiki GS, Kisanga ER, Boeree MJ, Aarnoutse RE. New drugs against tuberculosis: problems, progress, and evaluation of agents in clinical development. Antimicrob Agents Chemother. 2009;53(3):849–62.
2. Ginsberg AM. Drugs in development for tuberculosis. Drugs. 2010;70:2201–14.
3. Field SK, Fisher D, Jarand JM, Cowie RL. New treatment options for multidrug-resistant tuberculosis. Ther Adv Respir Dis. 2012;6(5):255–68.
4. Villemagne B, Crauste C, Flipo M, Baulard AR, Deprez B, Willand N. Tuberculosis: the drug development pipeline at a glance. Eur J Med Chem. 2012;51:1–16.
5. Otsuka Pharmaceutical. Otsuka Wins European Marketing Authorization for Deltyba(TM) (delamanid). Media Release. 20 Apr 2014. Available at http://www.otsuka.co.jp/en/company/release/2014/0430_01.html . Accessed 14 May 2014.
Cited by
143 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献